Life Sciences

There is no one-size-fits-all approach for life sciences clients.  But, our integrated intellectual property, regulatory, litigation, and corporate practices provide a one-size-fits-all TEAM for all clients.  We help entrepreneurs launch great ideas from the lab.  We help growing companies get funded and navigate the complex web of regulatory approvals.  We help public companies remain compliant with SEC requirements.  We help investors and underwriters secure positions as industry leaders.  We help companies strategically expand and protect their IP assets – including the new terrain of artificial intelligence and machine learning.  And, we assist clients in mitigating risk and navigating high-stakes commercial, regulatory, and IP litigation.  Life sciences companies rely on Mintz to address all of their legal needs at all stages of their life cycle.

• Corporate – $43B+ in transactions handled since 2020 for industry clients, including public offerings, joint ventures, licensing and complex collaborations, mergers and acquisitions, divestitures, distribution deals, and private financings.
• Intellectual Property – more than 115 professionals who represent clients in prosecution, strategy, business transactions, and litigation – 35+ of whom have biology or chemistry PhDs.
• Litigation – national reputation as go-to firm for high-stakes life sciences litigation, with an exemplary record in resolving disputes with collaboration/licensing partners in court and in arbitration, and representing corporate officers and directors of life sciences companies in disputes.
• Regulatory – advice spanning FDA strategy and interactions, clinical trials, fraud and abuse, compliance program development, HIPAA, marketing and advertising, drug pricing and reimbursement, and supply and distribution agreements.

Areas of focus: